Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Atea Pharmaceuticals, Inc."
Count: 26
Selected: 0
| NCT ID | Title |
|---|
| NCT05629962 | SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 | ||
| NCT05904470 | A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV | ||
| NCT05618314 | Study of AT-527 in Subjects With Normal and Impaired Renal Function | ||
| NCT05905497 | The Study of Bemnifosbuvir in Healthy Japanese Subjects | ||
| NCT05905484 | Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects | ||
| NCT05731843 | Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir | ||
| NCT05366439 | Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model | ||
| NCT05466240 | Study of AT-752 in Patients With Dengue Infection | ||
| NCT04396106 | Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting | ||
| NCT05724693 | Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function | ||
| NCT05256732 | Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal | ||
| NCT04722627 | Study of AT-752 in Healthy Subjects | ||
| NCT04309734 | Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects | ||
| NCT05137626 | Drug-drug Interaction Study of Digoxin and AT-527 (R07496998) | ||
| NCT05154123 | Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998) | ||
| NCT05004415 | Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998) | ||
| NCT04877769 | Bronchopulmonary PK of AT-527 (R07496998) | ||
| NCT04711187 | Study of AT-527 in Healthy Subjects (R07496998) | ||
| NCT04849299 | Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998) | ||
| NCT04865445 | Drug-drug Interaction Study of Midazolam and AT-527 (R07496998) | ||
| NCT04784000 | Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527 | ||
| NCT04019717 | Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection | ||
| NCT03219957 | Study of AT-527 in Healthy and HCV-Infected Subjects | ||
| NCT05059080 | A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study | ||
| NCT04709835 | Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19 | ||
| NCT04889040 | Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19 |
